Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: A systematic review

Oncologist

Volumn 17, Issue 11, 2012, Pages 1475-1481

  Davis, Esther L ^a   Oh, Byeongsang ^a,b,c   Butow, Phyllis N ^a   Mullan, Barbara A ^a   Clarke, Stephen ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Complementary and alternative medicine; Disclosure; Doctor patient relations

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; CANCER PATIENT; CONSULTATION; DATA EXTRACTION; DOCTOR PATIENT RELATION; FOOD DRUG INTERACTION; HEALTH SURVEY; HERB DRUG INTERACTION; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; MEDICAL LITERATURE; OUTCOMES RESEARCH; PATIENT SAFETY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WELLBEING;

ATTITUDE OF HEALTH PERSONNEL; COMMUNICATION; COMPLEMENTARY THERAPIES; DISCLOSURE; HUMANS; NEOPLASMS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS;

EID: 84869436625     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0223     Document Type: Article

References (49)

1. U.S. Department of Health. National Health Interview Survey (NHIS). Washington, DC: U.S. Department of Health, 2002.
2. Hyodo I, Amano N, Eguchi K et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005;23:2645-2654.
3. Jacobson JS, Workman SB, Kronenberg F. Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol 2000;18:668-683.
4. Owen DK, Lewith G, Stephens CR et al. Can doctors respond to patients' increasing interest in complementary and alternative medicine? BMJ 2001;322: 154-158.
5. Mao J, Palmer C, Healy K et al. Complementary and alternative medicine use among cancer survivors:Apopulation- based study. J Cancer Surviv 2011;5:8-17.
6. Richardson MA, Sanders T, Palmer JL et al. Complementary/ alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514.
7. Myers C, Stuber ML, Bonamer-Rheingans JI et al. Complementary therapies and childhood cancer. Cancer Control 2005;12:172-180.
8. Oh B, Butow P, Mullan B et al. Patient-doctor communication: The use of complementary and alternative medicine by adult patients with cancer. J Soc Integr Oncol 2010;8:56-64.
9. Miller M, Boyer MJ, Butow PN et al. The use of unproven methods of treatment by cancer patients: Frequency, expectations, and cost. Support Care Cancer 1998;6:337-347.
10. Sawyer MG, Gannoni AF, Toogood IR et al. The use of alternative therapies by children with cancer. Med J Aust 1994;160:320-322.
11. Shen J, Andersen R, Albert P et al. Use of complementary/ alternative therapies by women with advancedstage breast cancer. BMC Complement Altern Med 2002;2:8.
12. Molassiotis A, Fernadez-Ortega P, Pud D et al. Use of complementary and alternative medicine in cancer patients: A European survey. Ann Oncol 2005;16:655-663.
13. Ritvo P, Irvine J, Katz J et al. The patient's motivation in seeking complementary therapies. Patient Educ Couns 1999;38:161-165.
14. Verhoef MJ, Balneaves LG, Boon HS et al. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: A systematic review. Integr Cancer Ther 2005; 4:274-286.
15. Helyer LK, Chin S, Chui BK et al. The use of complementary and alternative medicines among patients with locally advanced breast cancer-A descriptive study. BMC Cancer 2006;6:39.
16. Boon H, Stewart M, Kennard MA et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000;18:2515-2521.
17. Burstein HJ, Gelber S, Guadagnoli E et al. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-1739.
18. Oh B, Butow P, Mullan B et al. The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia Pac J Clin Oncol 2010;6:342-349.
19. National Institutes of Health. What is complementary and alternative medicine? Available at http://nccam.nih.gov/health/whatiscam/. Accessed June 20, 2008.
20. Richardson MA. Biopharmacologic and herbal therapies for cancer: research update from NCCAM. J Nutrition 2001;131:3037S-30340S.
21. Boyle FM. Adverse interaction of herbal medicine with breast cancer treatment. Med J Aust 1997;167:286.
22. Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-329.
23. Tasaki K, Maskarinec G, Shumay DM et al. Communication between physicians and cancer patients about complementary and alternative medicine: Exploring patients' perspectives. Psychooncology 2002;11: 212-220.
24. Roberts CS, Baker F, Hann D et al. Patient-physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 2005;23:35-60.
25. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990 -1997. Results of a follow-up national survey. JAMA 1998;280:1569-1575.
26. Sagar SM. Integrative oncology in North America. J Soc Integr Oncol 2006;4:27-39.
27. Kmet L, Lee RC, Cook LS. Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields. Alberta, Canada: Institute of Health Economics, 2004.
28. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. Med J Aust 1996;165:545-548.
29. Adler SR, Fosket JR. Disclosing complementary and alternative medicine use in the medical encounter: A qualitative study in women with breast cancer. J Fam Pract 1999;48:453-458.
30. Balneaves LG, Kristjanson LJ, Tataryn D. Beyond convention: Describing complementary therapy use by women living with breast cancer. Patient Educ Couns 1999;38:143-153.
31. Nam RK, Fleshner N, Rakovitch E et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis. J Urol 1999;161:1521-1524.
32. Verhoef MJ, Hagen N, Pelletier G et al. Alternative therapy use in neurologic diseases: Use in brain tumor patients. Neurology 1999;52:617-622.
33. Ashikaga T, Bosompra K, O'Brien P et al. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 2002;10:542-548.
34. Powell CB, Dibble SL, Dall'Era JE et al. Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer 2002;12:214-217.
35. Tough SC, Johnston DW, Verhoef MJ et al. Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada. Altern Ther Health Med, 2002;8:54-64.
36. Boon H, Westlake K, StewartMet al. Use of complementary/ alternative medicine by men diagnosed with prostate cancer: Prevalence and characteristics. Urology 2003;62:849-853.
37. Eng J, Ramsum D, Verhoef M, et al. A populationbased survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2003;2:212-216.
38. Saxe GA, Madlensky L, Kealey S et al. Disclosure to physicians of CAM use by breast cancer patients: Findings from the Women's Healthy Eating and Living Study. Integr Cancer Ther 2008;7:122-129.
39. Chow WH, Chang P, Lee SC et al. Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singapore 2010;39:129-135.
40. Oh B, Butow P, Mullan B et al. Patient-doctor communication: The use of complementary and alternative medicine by adult patients with cancer. J Soc Integr Oncol 2010;8:56-64.
41. Rausch SM, Winegardner F, Kruk KM et al. Complementary and alternative medicine: Use and disclosure in radiation oncology community practice. Support Care Cancer 2011;19:521-529.
42. Butler S, Owen-Smith A, Diiorio C et al. Use of complementary and alternative medicine among men with prostate cancer in a rural setting. J Community Health 2011;36:1004-1010.
43. Al-Qudimat MR, Rozmus CL, Farhan N. Family strategies for managing childhood cancer: Using complementary and alternative medicine in Jordan. J Adv Nurs 2011;67:591-597.
44. Greasley P. Is evaluating complementary and alternative medicine equivalent to evaluating the absurd? Eval Health Prof 2010;33:127-139.
45. Sanchez-Ortuno MM, Belanger L, Ivers H et al. The use of natural products for sleep: A common practice? Sleep Med 2009;10:982-987.
46. Pendleton DA. Doctor-patient communication: A review. In: Pendleton D, Hasler J, eds. Doctor-Patient Communication. London: Academic Press, 1983:5-53.
47. Charles C, Gafni A, Whelan T. Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expect 2004;7:338-348.
48. National Health and Medical Research Council. Communicating with Patients: Advice for Medical Practitioners. Canberra, Australia; Australian Government Publishing Service, 2004.
49. Salzburg Global Seminar. Salzburg statement on shared decision making. BMJ 2011;342:d1745.